XML 43 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Description of Business and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2024
Description of Business and Summary of Significant Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash The following is a summary of cash, cash equivalents and restricted cash at March 31, 2024 and December 31, 2023:
(in thousands)  March 31,
2024		   December 31,
2023		 
Cash and cash equivalents  $84,057   $76,677 
Restricted cash – long-term   316    313 
Cash, cash equivalents and restricted cash  $84,373   $76,990 
Schedule of Computation of Diluted Net Loss Per Share For the three months ended March 31, 2024 and 2023, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units and warrants, have not been included in the computation of diluted net loss per share as the result would have been anti-dilutive.
(in thousands)  March 31,
2024		   March 31,
2023		 
Stock Options   5,421    3,324 
Restricted Stock Units   305    325 
Warrants   1,439    1,443 
Total   7,165    5,092